Biochips (Microarrays/Lab-on-Chip) Global Market

2015
IQ4I Research &
Consultancy Pvt. Ltd.
info@iq4i.com
www.iq4i.com
– Forecast to 2021
Copyright © 2015 IQ4I
All Rights Reserved. This document contains highly confidential
information and is the sole property of IQ4I. No part of it may be
circulated, copied, quoted, or otherwise reproduced without the
approval of IQ4I.
[TYPES (Microarrays and Lab-on-Chip (LOC)/Microfluidics),
PRODUCTS (Instruments, Reagents & Consumables, Software and
Services) APPLICATIONS (Diagnostics, Drug discovery and
development, Research, Forensic and Others), END-USERS
(Diagnostic laboratories, Pharmaceutical & Biotech companies,
CRO’s, Academic and research labs and Others), REGIONAL (North
America, Europe, Asia Pacific and Rest of the World)]
Bio-Chips (Microarrays/Lab-on-Chip) Global Market

IQ4I Research & Consultancy Pvt. Ltd. Page 2
–Forecast to 2021

–Forecast to 2021

–Forecast to 2021
1.1 REPORT DESCRIPTION
Biochips come handy as thousands of experiments are performed on a small chip with a solid
platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as
its application varies from high throughput screening in drug discovery to personalized
medicine.
The global biochips market is broadly classified as micro arrays and lab on chips based on its
type. Biochips market is segmented on the basis of application as diagnostic, drug discovery
and development, research, forensic and others. Based on the products the biochips market is
further segmented into instruments, reagents and consumables, software and services.
The global biochips market is expected to grow at a CAGR of around XX% from 2015 to 2021.
Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the
demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic
diseases, approval for personalized medicines and invention of novel technologies in biochips
drives the market of biochips. Standardization and quality assurance of biochips, technological
ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along
with ethical and social issues hinders the market growth.
Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early
diagnosis and treatment of diseases, advancement of biochips with its wide application areas
shows that biochip market has vast opportunities in the coming years.
North America accounts for the highest market share followed by Europe. Steep rise in genetic
diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines
and favourable government policies makes U.S. the leader of Biochips market. However, Asian
countries especially India and China’s are the fast growing regions with its growing demand for
biochips and increasing research investments.
Major players in biochips market include Affymetrix, Inc. (U.S.), Agilent Technologies (U.S.),
Bio-Rad Laboratories (U.S.), Cepheid, Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare
(U.K.), Hoffman-La-Roche (Switzerland), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.) and
Thermo Fisher Scientific, Inc. (U.S.).

–Forecast to 2021
The report provides an in depth market analysis of the above mentioned segments across the
following regions:
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)

–Forecast to 2021
TABLE 1
BIOCHIPS GLOBAL MARKET REVENUE, BY REGION,
(2013-2021) ($MN)
Region 2013 2014 2015 2021
CAGR (%)
(2015-2021)
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia-Pacific XX XX XX XX XX
RoW XX XX XX XX XX
Total XX XX XX 13,129 XX
Source: American Genetic Association (AGA), Genome Wide Association (GWA), American Society of Gene Therapy
(ASGT), Nanotechnology and Integrated Microsystems Associations (NIMA), International Electrotechnical
Commission (IEC), MEMS Associations, World Health Organization (WHO), Industry expert Interviews, and IQ4I
analysis
North America commanded the largest revenue of $XX million of the global biochips market in
2014. The market is expected to grow at a CAGR of 15% from 2015 to 2021 to reach $XX
million by 2021. Asia Pacific is expected to grow at a strong CAGR of XX% during the forecast
period.

–Forecast to 2021
TABLE 2
BIOCHIPS GLOBAL MARKET REVENUE, BY TYPE,
(2013-2021) ($MN)
Type 2013 2014 2015 2021
CAGR (%)
(2015-2021)
Microarrays XX XX XX XX XX
Lab-on-chips XX XX XX XX XX
Total XX XX XX XX XX
analysis
Microarrays commanded the largest revenue of $XX million of the global biochips market in
2014. The market is expected to grow at a CAGR of XX% from 2015 to 2021 to reach $XX
million by 2021. Lab-on-chips are expected to grow at a strong CAGR of XX% during the
forecast period.

–Forecast to 2021
FIGURE 1
BIOCHIPS GLOBAL MARKET REVENUE, BY PRODUCTS,
(2014 V’S 2021) ($MN)
Instruments Reagentandconsumables Software Services
2014
2021
Marketsize($Mn)

–Forecast to 2021
TABLE 3
BIOCHIPS GLOBAL MARKET REVENUE, BY APPLICATION TYPE
(2013-2021) ($MN)
Type 2013 2014 2015 2021
CAGR (%)
(2015-2021)
Diagnostics XX XX XX XX XX
Drug discovery and development XX XX XX XX XX
Research XX XX XX XX XX
Forensics XX XX XX XX XX
Others XX XX XX XX XX
analysis
Diagnostics commanded the largest revenue of $XX million of the global biochips application
market in 2014. The market is expected to grow at a highest CAGR of XX% from 2015 to 2021
to reach $XX million by 2021.

–Forecast to 2021
TABLE 4
BIOCHIPS GLOBAL MARKET REVENUE, BY END USERS TYPE,
(2013-2021) ($MN)
Type 2013 2014 2015 2021
CAGR (%)
(2015-2021)
Pharmaceuticals & biotech companies XX XX XX XX XX
CRO's XX XX XX XX XX
Academic & research laboratories XX XX XX XX XX
Diagnostic laboratories XX XX XX XX XX
Others XX XX XX XX XX
analysis
Diagnostic laboratories commanded the largest revenue of $XX million of the global biochips
end users market in 2014. The market is expected to grow at a CAGR of XX% from 2015 to
2021 to reach $XX million by 2021. Pharmaceuticals and biotech companies are expected to
grow at a strong double digit CAGR of XX% during the forecast period.

–Forecast to 2021
Disclaimer: IQ4I strategic analysis services are limited publications containing valuable market
information provided to a select group of customers in response to orders. Our customers
acknowledge, when ordering, that IQ4I strategic analysis services are for our customers’
internal use and not for general publication or disclosure to third parties. Quantitative market
information is based primarily on interviews and therefore, is subject to fluctuation.
IQ4I does not endorse any vendor, product or service depicted in its research publications. IQ4I
strategic analysis publications consist of the opinions of IQ4I' research and should not be
construed as statements of fact. IQ4I disclaims all warranties, expressed or implied, with
respect to this research, including any warranties of merchantability or fitness for a particular
purpose.
IQ4I takes no responsibility for any incorrect information supplied to us by manufacturers or
users.
All trademarks, copyrights and other forms of intellectual property belong to their respective
owners and may be protected by copyright. Under no circumstance may any of these be
reproduced in any form without the prior written agreement of their owner.
No part of this strategic analysis service may be given, lent, resold or disclosed to non-
customers without written permission.
Reproduction and/or transmission in any form and by any means including photocopying,
mechanical, electronic, recording or otherwise, without the permission of the publisher is
prohibited.
For information regarding permission, contact:
Tel: +91 80 60500229
Email: bd@IQ4I.com

Biochips (Microarrays/Lab-on-Chip) Global Market

Recommended

Recommended

More Related Content

Recently uploaded

Recently uploaded (20)

Featured

Featured (20)

Biochips (Microarrays/Lab-on-Chip) Global Market